Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 357,712 | 198,911 | 207,981 | 176,084 | 157,025 |
| Receivables | 245,546 | 275,296 | 281,119 | 296,507 | 279,072 |
| Inventories | 338,082 | 316,054 | 302,622 | 296,505 | 286,962 |
| TOTAL | $1,008,672 | $858,168 | $883,813 | $868,672 | $822,686 |
| Non-Current Assets | |||||
| PPE Net | 335,903 | 337,404 | 319,384 | 316,445 | 306,350 |
| Intangibles | 1,965,781 | 1,985,871 | 1,985,632 | 1,968,352 | 1,981,138 |
| Other Non-Current Assets | 137,209 | 121,797 | 157,751 | 136,941 | 95,537 |
| TOTAL | $2,438,893 | $2,445,072 | $2,462,767 | $2,421,738 | $2,383,025 |
| Total Assets | $3,447,565 | $3,303,240 | $3,346,580 | $3,290,410 | $3,205,711 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 3,984 | 3,507 | 33,750 |
| Accounts payable and accrued liabilities | 97,061 | 113,090 | 94,158 | 107,191 | 100,553 |
| Accrued Expenses | 131,600 | 156,194 | 147,664 | 145,965 | 150,053 |
| Other current liabilities | 4,860 | 4,772 | N/A | N/A | N/A |
| TOTAL | $246,485 | $331,309 | $302,641 | $315,111 | $288,106 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,116,532 | 1,303,061 | 1,274,049 | 1,204,537 | 1,205,025 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 3,750 |
| Other Non-Current Liabilities | 718,524 | 215,581 | 325,186 | 296,725 | 257,890 |
| TOTAL | $1,859,277 | $1,555,195 | $1,658,965 | $1,554,348 | $1,520,575 |
| Total Liabilities | $2,105,762 | $1,886,504 | $1,961,606 | $1,869,459 | $1,808,681 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,843 | 84,443 | 85,866 | 85,534 | 85,477 |
| Common Shares | 889 | 887 | 886 | 883 | 882 |
| Retained earnings | 407,553 | 398,574 | 383,255 | 410,865 | 381,129 |
| Other shareholders' equity | -104,094 | -76,345 | -87,716 | -68,807 | -56,788 |
| TOTAL | $1,341,803 | $1,416,736 | $1,384,974 | $1,420,951 | $1,397,030 |
| Total Liabilities And Equity | $3,447,565 | $3,303,240 | $3,346,580 | $3,290,410 | $3,205,711 |